Streetbeat News

Stock Prices

NRIX

Nurix Therapeutics shares rose following the announcement of better-than-expected Q3 EPS results.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 8:02 pm

NRIX

Nurix Therapeutics reported a Q3 2024 GAAP EPS of $(0.67), beating the estimate of $(0.70), but sales of $12.588M missed the $13.248M estimate. Sales decreased by 31.84% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 8:01 pm

CHD

Church & Dwight Co (NYSE:CHD) has been evaluated by 14 analysts over the past three months, with a mix of bullish and bearish opinions. The average 12-month price target is $101.71, showing a slight increase from the previous target. The company has shown strong revenue growth and net margin, but its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 8:01 pm

SFIX

Analysts have provided mixed ratings for Stitch Fix (NASDAQ:SFIX) over the past three months, with a recent trend towards neutral ratings. The average 12-month price target has decreased by 12.25% to $3.58. Financial performance shows challenges with declining revenue, negative net margin, and low ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 8:01 pm

DAR

Darling Ingredients (NYSE:DAR) has been analyzed by four analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has decreased by 6.67% to $45.5. Analysts have lowered their price targets, reflecting a cautious outlook. Despite challenges in revenue growth, Darling Ingredients maintains strong net margins and ROE, but faces high debt levels.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 8:01 pm

VRA

Vera Bradley, Inc. has adopted a limited duration shareholder rights plan to protect shareholders' interests and maximize value. The plan aims to prevent any entity from gaining control without negotiating with the Board and paying a control premium. It is effective immediately and will expire on October 11, 2025.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 8:01 pm

FRT

Federal Realty Investment (NYSE:FRT) has been analyzed by 12 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $123.5, reflecting a 6.47% increase from the previous target. Analysts have adjusted their ratings and price targets, with several raising their targets. FRT's financial health is strong, with high market capitalization, revenue growth, and profitability metrics.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 8:00 pm

USO

The U.S. Treasury Department has imposed new sanctions on Iran's petroleum and petrochemical sectors following Iran's attack on Israel. These sanctions aim to cut off revenue for Iran's destabilizing activities. Despite the sanctions, crude oil prices remained stable, with WTI light crude slightly down.

Portfolio Pulse from Piero Cingari

October 11, 2024 | 7:59 pm

VERB

Verb Technology's shares surged after CEO Rory J. Cutaia's optimistic shareholder letter highlighted the company's strong financial position and undervaluation. The letter detailed Verb's market cap, cash holdings, and restructuring into a holding company with promising business units. The stock rose 47.8% to $7.70.

Portfolio Pulse from Vaishali Prayag

October 11, 2024 | 7:57 pm

TSLA

UBER

Tesla's recent 'We, Robot' event introduced the CyberCab and RoboVan, but analysts believe it poses minimal near-term threat to Uber. Analysts from Bank of America and Truist Securities maintain a positive outlook on Uber, emphasizing its strong position in the autonomous vehicle (AV) space.

Portfolio Pulse from Surbhi Jain

October 11, 2024 | 7:47 pm